Amgen (AMGN) PT Lowered to $378 at Guggenheim
Guggenheim analyst Vamil Divan lowered the price target on Amgen (NASDAQ: AMGN) to $378.00 while maintaining a Neutral rating.
Guggenheim analyst Vamil Divan lowered the price target on Amgen (NASDAQ: AMGN) to $378.00 while maintaining a Neutral rating.